Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 1.313
+0.021 (1.63%)
Oct 13, 2026, 11:38 AM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 370.19 million as of October 12, 2026. It is the 32,724th most valuable company in the world and the 438th biggest in Sweden. Its market cap has decreased by 44.44% in one year.
Market Cap
370.19M
Enterprise Value
148.24M
Revenue
317.31M
Global Rank
Country Rank
#438 Sweden
PE Ratio
1.93
ChartMarket Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 370.19M, an increase of 207.08%. That is a compound annual growth rate of 10.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 386.26M | -62.87% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AlzeCure Pharma AB | 932.19M |
| FluoGuide | 518.27M |
| Xspray Pharma AB | 507.36M |
| Sprint Bioscience AB | 385.13M |
| Mendus AB | 381.31M |
| Corline Biomedical AB | 358.02M |
| Intervacc AB | 302.30M |
| Xbrane Biopharma AB | 287.44M |